Gastroesophageal reflux disease increases predisposition to severe COVID‐19: Insights from integrated Mendelian randomization and genetic analysis
2025
GERD and Severe COVID-19 Risk
Sample size: 602604
publication
10 minutes
Evidence: high
Author Information
Author(s): Pan Jingjing, Li Jianhua
Primary Institution: Zhejiang Provincial Centers for Disease Control and Prevention
Hypothesis
Does gastroesophageal reflux disease (GERD) increase the risk of severe COVID-19?
Conclusion
Genetically determined GERD may increase susceptibility to hospitalized and severe COVID-19.
Supporting Evidence
- GERD showed a significant positive genetic correlation with hospitalized COVID-19.
- The MR analysis indicated a causal effect of GERD on COVID-19 outcomes.
- Shared genomic loci were identified between GERD and COVID-19.
- Colocalization analysis showed significant correlations between GWAS and eQTL abnormalities.
- Molecular pathway analysis indicated GERD may influence COVID-19 through immune-related pathways.
Takeaway
People with GERD might get sicker if they catch COVID-19 because of their genes.
Methodology
The study used Mendelian randomization and genetic analysis to explore the relationship between GERD and COVID-19.
Potential Biases
Potential bias from pleiotropy in the genetic data.
Limitations
The study focused only on genetic factors and did not consider environmental influences.
Participant Demographics
Participants were of European descent.
Statistical Information
P-Value
9.17e−12
Confidence Interval
1.27–1.44
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website